Cytomos’ AuraCyt Digital Predictive Cell Analytics Platform Showcased at BIO Conference
Cytomos reports that it is showcasing its flagship cell analytic intelligence platform AuraCyt®, together with its novel Celledonia®benchtop technology, which is designed to boost predictive cell analytics. Current challenges in the bioprocessing space include slow, label-dependent analytical methods that are inefficient to scale-up and provide limited predictive insight, according to Cytomos.
The AuraCyt platform measures intrinsic cell physics to generate AI-ready digital fingerprints that reveal the multi-dimensional state and behavior of the cell. The benchtop cell analytics intelligence system combines the compact Celledonia analyzer with the sensors of the AuraCyt modules to transform complex cellular data into actionable insights, notes a Cytomos spokesperson, who points out that this label-free, single-cell analysis system predicts future productivity, stability, and manufacturability.
This enables earlier insights and real-time decision-making, lowering risk, providing scalable impact, optimizing process and improving product consistency, says the spokesperson. The operation reportedly provides demonstrable value across various applications, such as reducing CLD timelines by up to 40%, saving up to 65% of resources in lentivirus batch production, and reducing CAR T process time by up to 30%, comments Cytomos’ executive chair, Alan Raymond.
The company is showcasing this technology at its pod in BIO Business Forum Zone D (Exhibit Hall 2221 UK Pavillion), from 22-25thof June, 2026.
NewsArtificial intelligenceBioprocessingConferencesLentivirusT-cell immunotherapyCytomosAuraCytCelledoniaPrevious article
Long‑Range Gene Networks Uncover 641 New Schizophrenia‑Associated GenesNext article
Nextgen Platform Combines VectorBuilder and Maxcyte Technologies to Boost Clinical-Grade Cell EngineeringAlso of Interest
CloudScope Enables Continuous Remote Monitoring of Brain Activity in Freely Moving MiceTranscenta Therapeutics and WuXi Biologics Team Up to Accelerate Commercialization of HiCB TechnologySmarter Cell Culture Starts with Better MediaCAR T Manufacturing in Japan Gets Boost from Teijin-Shinshu University Research CollaborationRevvity Signs Agreement to Acquire Human Cell DesignTop 10 Contract Development and Manufacturing Organizations 2026Related Media
Data Integrity as the Foundation for AISmall Molecules, Big Expectations: How CDMOs Are Helping Sponsors Navigate Complexity, Speed, Scale-Up, and SustainabilityBeyond the Technology: AI Readiness in Regulated LaboratoriesAACR 2026 Video Update: Cancer Research Edges Toward an AI-Driven EraAACR 2026: A Video Update from San DiegoOmics in Orlando Day 2: A Video Report from AGBTTop 5ResourcesRecommended For YouPodcast
Touching Base
Touching Base is the dynamic podcast series from the editors ofGEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex Phillippidis, Uduak Thomas, Corinna Singleman, and Fay Lin—who delve into emerging stories, exchange ideas, and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what's now and next.Start listening today!
Stay up to date with the lasted episodes of Touching Base bysubscribing to theGENPodcast Newsletter
